Medicine & Life Sciences
Dengue Vaccines
100%
SARS Virus
96%
Dengue
74%
Heart Transplantation
68%
Dengue Virus
67%
Coinfection
63%
Risk Assessment
54%
Infections
51%
Biomarkers
42%
Vaccines
30%
Transplant Recipients
30%
Immunocompromised Host
23%
Heart
21%
Immunosuppression
19%
Torque teno virus
16%
Vaccination
15%
Serogroup
14%
Tonga
14%
Cell-Free Nucleic Acids
13%
Viruses
10%
High-Throughput Nucleotide Sequencing
10%
Seroconversion
9%
Viremia
9%
Immunity
8%
Population
8%
National Institutes of Health (U.S.)
8%
Neutropenia
8%
Neutralizing Antibodies
8%
Exanthema
8%
Medicine
7%
Disease Outbreaks
7%
Communicable Diseases
6%
Morbidity
6%
Survival
6%
Therapeutics
5%
Mortality
5%
Agriculture & Biology
vaccine development
81%
dengue
77%
Dengue virus
60%
vaccines
39%
infection
34%
therapeutics
15%
serotypes
11%
neutropenia
9%
National Institutes of Health
9%
Tonga
9%
viruses
8%
viremia
8%
seroconversion
8%
neutralizing antibodies
7%
infrastructure
7%
health services
6%
infectious diseases
6%
vaccination
5%
Social Sciences
candidacy
39%
military
22%
Polynesia
17%
vaccination
14%
contagious disease
12%
health care
9%
infrastructure
9%
cause
7%
health
5%
evaluation
5%